The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, and growing importance in technologies such as machine learning, augmented reality, 5G and digitalization. In the last three years alone, there have been over 710,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Environmental sustainability in medical: biocompatible expandable stents. Buy the report here.
According to GlobalData’s Technology Foresights, which uses over 155,000 patents to analyze innovation intensity for the medical devices industry, there are 30+ innovation areas that will shape the future of the industry.
Biocompatible expandable stents is a key innovation area in environmental sustainability
Biocompatible expandable stents are medical devices used for treating various conditions within the human body, particularly in blood vessels and the skeletal system. These stents are designed to be implanted in a compressed form and then expanded to provide structural support and promote the natural healing process. They are typically made from biodegradable materials, such as polylactic acid or polyglycolic acid, and may incorporate coatings or reinforcing components to enhance their functionality and biocompatibility.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 780+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of biocompatible expandable stents.
Key players in biocompatible expandable stents – a disruptive innovation in the medical devices industry
‘Application diversity’ measures the number of applications identified for each patent. It broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of countries each patent is registered in. It reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to biocompatible expandable stents
|Company||Total patents (2010 - 2022)||Premium intelligence on the world's largest companies|
|Edwards Lifesciences||1692||Unlock Company Profile|
|Medtronic||1551||Unlock Company Profile|
|Abbott Laboratories||1339||Unlock Company Profile|
|Boston Scientific||1293||Unlock Company Profile|
|W. L. Gore & Associates||954||Unlock Company Profile|
|Johnson & Johnson||933||Unlock Company Profile|
|Cook Group||480||Unlock Company Profile|
|Becton Dickinson||453||Unlock Company Profile|
|Terumo||387||Unlock Company Profile|
|Stryker||341||Unlock Company Profile|
|Venus Medtech Hangzhou||227||Unlock Company Profile|
|Sofradim Production||221||Unlock Company Profile|
|AbbVie||192||Unlock Company Profile|
|Smith & Nephew||164||Unlock Company Profile|
|Micell Technologies||129||Unlock Company Profile|
|ConforMIS||118||Unlock Company Profile|
|Zimmer Biomet||117||Unlock Company Profile|
|LifeTech Scientific||112||Unlock Company Profile|
|Endologix||110||Unlock Company Profile|
|Elixir Medical||105||Unlock Company Profile|
|Getinge||104||Unlock Company Profile|
|Hellman & Friedman||101||Unlock Company Profile|
|Biotronik||97||Unlock Company Profile|
|Toray Industries||96||Unlock Company Profile|
|The Cigna Group||92||Unlock Company Profile|
|Vactronix Scientific||89||Unlock Company Profile|
|4C Medical Technologies||87||Unlock Company Profile|
|Q3 Medical Devices||87||Unlock Company Profile|
|Merit Medical Systems||84||Unlock Company Profile|
|MicroPort Scientific||82||Unlock Company Profile|
|Aortic Innovations||82||Unlock Company Profile|
|Globus Medical||80||Unlock Company Profile|
|CorMatrix Cardiovascular||79||Unlock Company Profile|
|Nipro||77||Unlock Company Profile|
|JenaValve Technology||76||Unlock Company Profile|
|Olympus||76||Unlock Company Profile|
|Medtentia International||74||Unlock Company Profile|
|SI-Bone||72||Unlock Company Profile|
|Kona Gold Beverage||69||Unlock Company Profile|
|Royal DSM||67||Unlock Company Profile|
|MiMedx Group||66||Unlock Company Profile|
|Provectus Biopharmaceuticals||66||Unlock Company Profile|
|Taewoong Medical||64||Unlock Company Profile|
|Vdyne||64||Unlock Company Profile|
|The Cleveland Clinic Foundation||60||Unlock Company Profile|
|Woodwelding||58||Unlock Company Profile|
|OrbusNeich||57||Unlock Company Profile|
|Cardinal Health||57||Unlock Company Profile|
|REVA Medical||57||Unlock Company Profile|
|ValCare||56||Unlock Company Profile|
Source: GlobalData Patent Analytics
Edwards Lifesciences and Medtronic are two of the leading patent filers in biocompatible expandable stents. Some other key patent filers include Abbott Laboratories, Boston Scientific, and W. L. Gore & Associates.
In terms of application diversity, Micell Technologies leads the pack, while CorMatrix Cardiovascular and Toray Industries stood in the second and third positions, respectively. By means of geographic reach, Aortic Innovations held the top position, followed by 4C Medical Technologies and MiMedx Group.
Biocompatible expandable stents have a promising future, with ongoing improvements in materials and design. The demand for these stents is increasing as they could reduce the need for repeat interventions, improve patient outcomes, and contribute to the advancement of personalized medicine.
To further understand the key theme and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.